Belite Bio (Belite Bio) Other Long Term Assets : $4.68 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Belite Bio Other Long Term Assets?

Belite Bio's other long-term assets for the quarter that ended in Mar. 2024 was $4.68 Mil.

Belite Bio's quarterly other long-term assets declined from Sep. 2023 ($1.46 Mil) to Dec. 2023 ($0.17 Mil) but then increased from Dec. 2023 ($0.17 Mil) to Mar. 2024 ($4.68 Mil).

Belite Bio's annual other long-term assets declined from Dec. 2021 ($0.82 Mil) to Dec. 2022 ($0.09 Mil) but then increased from Dec. 2022 ($0.09 Mil) to Dec. 2023 ($0.17 Mil).

Belite Bio Other Long Term Assets Historical Data

The historical data trend for Belite Bio's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belite Bio Other Long Term Assets Chart

Belite Bio Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

0.01

0.82

0.09

0.17

Belite Bio Quarterly Data
	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial							1.40	1.56	1.46	0.17	4.68

Belite Bio Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Belite Bio (Belite Bio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Belite Bio Inc (NAS:BLTE) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

D01:Germany

Address

12750 High Bluff Drive, Suite 475, San Diego, CA, USA, 92130

Website

https://www.belitebio.com

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.